A University of Manitoba expert is a vital part of an international team of scientists studying the alarming changes in the spread of mpox across the Democratic Republic of Congo (DRC) to better ...

Bavarian Nordic has secured a DKK 200 million+ vaccine contract in Europe, bringing total public‑preparedness deals to over ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Africa has recorded more than 4,200 deaths due to ongoing cholera and mpox outbreaks in different parts of the continent in ...

NNVC NanoViricides, Inc. (NYSE:NNVC) is a clinical-stage biopharmaceutical company developing a new class of broad-spectrum antiviral drugs known as “nanoviricides”. These agents mimic cell surface ...

Cholera and mpox outbreaks have killed 4,200 people in different parts of Africa, the Africa Centers for Disease Control and ...

Single dose vaccination with TNX-801 protects animals from a lethal challenge with monkeypox, the causative agent of mpox TNX ...

An analysis of mpox virus genomes from individuals infected between 2018 and 2023 has provided insights into how the virus ...

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

In March 2025, the Advisory Committee on Dangerous Pathogens (ACDP) advised that clade I mpox no longer meets the criteria for a high consequence infectious disease (HCID) and recommended derogation.

Vaccination and pre-departure education among Nepali travellers can prevent outbreaks.

Tonix Pharmaceuticals (TNXP) stock gains as the company posts peer-reviewed data for pain drug TNX-102 and new data for mpox ...